Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart

Background—Mechanical unloading of the failing human heart with a left ventricular assist device (LVAD) results in clinically documented reversal of chamber dilation and improvement of cardiac function. We tested the hypothesis that LVAD support normalizes the ability of cardiac muscle to respond to sympathetic nervous system stimulation by reversing the downregulation of &bgr;-adrenergic receptors. Methods and Results—Human LV tissue was obtained from nonfailing hearts of unmatched organ donors and failing hearts at the time of transplantation, with or without LVAD. Baseline contractile parameters and inotropic response to a &bgr;-adrenergic agonist were measured in isolated trabecular muscles. &bgr;-Adrenergic receptor density was quantified by radioligand binding. Results showed a significant increase in the response to &bgr;-adrenergic stimulation after LVAD (developed tension increased by 0.76±0.09 g/mm2 in nonfailing, 0.38±0.07 in failing, and 0.68±0.10 in failing+LVAD;P <0.01), accompanied by an increased density of &bgr;-adrenergic receptors (58.7±9.6 fmol/mg protein in nonfailing, 26.2±3.8 in failing, and 63.0±8.3 in failing+LVAD;P <0.05). These changes were unrelated to the duration of support. Conclusions—Data demonstrate that mechanically supporting the failing human heart with an LVAD can reverse the downregulation of &bgr;-adrenergic receptors and restore the ability of cardiac muscle to respond to inotropic stimulation by the sympathetic nervous system. This indicates that functional impairment of cardiac muscle in human heart failure is reversible.

[1]  M. Oz,et al.  Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. , 1998, The Journal of thoracic and cardiovascular surgery.

[2]  J. Sprung,et al.  Effects of Ketamine on the Contractility of Failing and Nonfailing Human Heart Muscles In Vitro , 1998, Anesthesiology.

[3]  B. Griffith,et al.  Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. , 1995, Chest.

[4]  D. Renlund,et al.  Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. , 1991, Circulation.

[5]  S. Houser,et al.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. , 1998, Circulation.

[6]  C H Davies,et al.  Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. , 1995, Circulation.

[7]  G. Noon,et al.  Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. , 1999, Circulation.

[8]  R Hetzer,et al.  Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. , 1997, Circulation.

[9]  F. Schoen,et al.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. , 1987, Circulation.

[10]  H Harasaki,et al.  Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. , 1996, Journal of the American College of Cardiology.

[11]  H. Drexler,et al.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.

[12]  M. Oz,et al.  Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. , 1998, Circulation.

[13]  Y. Takeishi,et al.  Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. , 2000, Cardiovascular research.

[14]  J. Sprung,et al.  The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles , 2000 .

[15]  M. Oz,et al.  Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. , 1997, The Annals of thoracic surgery.

[16]  V. Jeevanandam,et al.  Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  M. Böhm,et al.  Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. , 1996, Journal of the American College of Cardiology.

[18]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[19]  B. Griffith,et al.  Evolution of human cardiac myocyte dimension during prolonged mechanical support. , 1991, The Journal of thoracic and cardiovascular surgery.

[20]  J. Holtz,et al.  Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. , 1999, Circulation.

[21]  G. Schreiner,et al.  Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.

[22]  H Harasaki,et al.  Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group. , 1994, Circulation.

[23]  J. Thomas,et al.  Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. , 1995, Circulation.

[24]  D. Burkhoff,et al.  Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure , 2000, Circulation.

[25]  D. Burkhoff,et al.  PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) Defective Regulation in Failing Hearts , 2000, Cell.

[26]  O. Frazier,et al.  Improved left ventricular function after chronic left ventricular unloading. , 1996, The Annals of thoracic surgery.

[27]  S Hagl,et al.  Length dependence of calcium- and force-transients in normal and failing human myocardium. , 1998, Journal of molecular and cellular cardiology.

[28]  N. Alpert,et al.  Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. , 1992, Circulation research.

[29]  M C Oz,et al.  Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. , 1995, Circulation.

[30]  M. Olschewski,et al.  Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. , 1996, The Journal of clinical investigation.

[31]  S. Houser,et al.  Regression of cellular hypertrophy after left ventricular assist device support. , 1998, Circulation.